I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase II study to assess the efficacy, safety and tolerabil..:
Jones, Robert
;
Vuky, Jacqueline
;
Elliott, Tony
...
Investigational New Drugs. 31 (2013) 4 - p. 1001-1007 , 2013
Link:
https://doi.org/10.1007/s10637-013-9926-y
RT Journal T1
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s10637-013-9926-y&Exemplar=1&LAN=DE A1 Jones, Robert A1 Vuky, Jacqueline A1 Elliott, Tony A1 Mead, Graham A1 Arranz, José Angel A1 Chester, John A1 Chowdhury, Simon A1 Dudek, Arkadiusz Z. A1 Müller-Mattheis, Volker A1 Grimm, Marc-Oliver A1 Gschwend, Jürgen E. A1 Wülfing, Christian A1 Albers, Peter A1 Li, Jianguo A1 Osmukhina, Anna A1 Skolnik, Jeffrey A1 Hudes, Gary PB Springer Science and Business Media LLC YR 2013 SN 0167-6997 SN 1573-0646 JF Investigational New Drugs VO 31 IS 4 SP 1001 OP 1007 LK http://dx.doi.org/https://doi.org/10.1007/s10637-013-9926-y DO https://doi.org/10.1007/s10637-013-9926-y SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)